Zebrafish behavior monitoring system could boost drug discovery (w/ Video)

Jan 19, 2010

Researchers from the University of British Columbia and Harvard University have co-developed a system that captures on video and barcodes the behavioral responses of zebrafish to chemical compounds on a large scale. The approach could dramatically speed up the discovery of new psychiatric drugs.

The discovery in the 1950s of drugs that act in the nervous system has been important both for the understanding of neurobiology and the treatment of . Since then, very few new drugs have been developed.

The new system, detailed in today's edition of Nature Chemical Biology, was developed by UBC statisticians Jennifer Bryan and Rick White and Harvard's Randall Peterson and David Kokel. It can track the behavioral effects of up to 14,000 chemicals at a time and has already identified new chemicals that affect behaviour in fish.

This video is not supported by your browser at this time.
Movie of the PMR in zebrafish embryos in a petri dish at low magnification.

"The capacity of this approach is quite distinctive," says Bryan, an associate professor in the Department of Statistics and the Michael Smith Laboratories. "Most pharmacological studies of behaviour have been relatively small scale, involving a few small molecules at most."

"New represent new windows into how the brain works," says Randall Peterson of Harvard. "We hope that behavioral screens with will lead to many new compounds that help us understand and ultimately treat nervous system disorders."

Zebrafish models have increasingly been used to assess drug toxicity and safety, largely because they are transparent, genetically tractable, and have organ systems that are very similar to those of humans. Zebrafish embryos are permeable to drugs.

This video is not supported by your browser at this time.
Movie of the PMR behavior at 30 hpf, showing that animals do not normally respond to a second pulse of light.

Capable of screening approximately 5,000 zebrafish embryos per day, the new platform monitors the motion of embryos in response to two strong light pulses after exposure to chemicals, and compares that to untreated, controls. In total, the study evaluated the behavioral effects of compounds on more than a quarter million .

"The UBC team was able to help devise ways to turn these behavioral observations into more manageable barcodes that capture how the behavior in a treated group differs from that in an untreated, control," says Bryan, co-author of the study. "This makes it possible to generate visualizations of the massive screening datasets generated by this powerful tool, and to group compounds based on the similarity of their associated barcodes."

The new tool may also make it possible to generate genetic models of disorders and screen for chemical modifiers of the associated behavioral defects.

Explore further: A new synthetic amino acid for an emerging class of drugs

More information: doi:10.1038/nchembio.307

Related Stories

Zebrafish: It's not your parents' lab rat

Jul 30, 2007

Zebrafish cost about a dollar at the pet store. They grow from eggs to hunting their own food in three days. Adults can lay up to 500 eggs at once… and you have more in common with them than you think.

Recommended for you

A new synthetic amino acid for an emerging class of drugs

21 hours ago

Swiss scientists have developed a new amino acid that can be used to modify the 3-D structure of therapeutic peptides. Insertion of the amino acid into bioactive peptides enhanced their binding affinity up to 40-fold. Peptides ...

Protein glue shows potential for use with biomaterials

Aug 28, 2014

Researchers at the University of Milan in Italy have shown that a synthetic protein called AGMA1 has the potential to promote the adhesion of brain cells in a laboratory setting. This could prove helpful ...

User comments : 0